Resveratrol Co-Treatment Attenuates the Effects of HIV Protease Inhibitors on Rat Body Weight and Enhances Cardiac Mitochondrial Respiration

Systemic inflammation and residual viraemia in HIV-positive adults on protease inhibitor monotherapy: a cross-sectional study

(2015) Alejandro Arenas-Pinto et al.   BMC INFECTIOUS DISEASES

Acetyl salicylic acid attenuates cardiac hypertrophy through Wnt signaling

(2015) Samuel Chege Gitau et al.   Frontiers of Medicine

MECHANISMS IN ENDOCRINOLOGY: Metabolic and body composition effects of newer antiretrovirals in HIV-infected patients

(2014) Suman Srinivasa et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Impairments in mitochondrial palmitoyl-CoA respiratory kinetics that precede development of diabetic cardiomyopathy are prevented by resveratrol in ZDF rats

(2014) Marie-Soleil Beaudoin et al.   JOURNAL OF PHYSIOLOGY-LONDON

The burden of HIV

(2013) Katrina F. Ortblad et al.   AIDS

HIV protease inhibitors and onset of cardiovascular diseases: A central role for oxidative stress and dysregulation of the ubiquitin–proteasome system

(2013) Kathleen M.S.E. Reyskens et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

High clustering rates of multidrug-resistant Mycobacterium tuberculosisgenotypes in Panama

(2013) Samantha Rosas et al.   BMC INFECTIOUS DISEASES

The maladaptive effects of HIV protease inhibitors (lopinavir/ritonavir) on the rat heart

(2013) Kathleen M.S.E. Reyskens et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Cardio-Metabolic Effects of HIV Protease Inhibitors (Lopinavir/Ritonavir)

(2013) Kathleen M. S. E. Reyskens et al.   PLoS One

Aspirin may promote mitochondrial biogenesis via the production of hydrogen peroxide and the induction of Sirtuin1/PGC-1α genes

(2012) Pratibha Kamble et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

HIV-1, reactive oxygen species, and vascular complications

(2012) Kristi M. Porter et al.   FREE RADICAL BIOLOGY AND MEDICINE

Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients

(2011) Paula Freitas et al.   BMC INFECTIOUS DISEASES

Tits and bits of HIV Tat protein

(2011) Manish K Johri et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 mice

(2010) Paul J. Pistell et al.   ANTIVIRAL RESEARCH

High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy

(2010) K. E. Mondy et al.   CLINICAL INFECTIOUS DISEASES

Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study

(2010) Nina Friis-Møller et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Mechanisms of HIV-associated lymphocyte apoptosis: 2010

(2010) N W Cummins et al.   Cell Death & Disease

Cardiovascular manifestations of HIV infection

(2009) J. E Ho et al.   HEART

Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study

(2009) Signe Westring Worm et al.   JOURNAL OF INFECTIOUS DISEASES

Expression of mitochondrial regulatory genes parallels respiratory capacity and contractile function in a rat model of hypoxia-induced right ventricular hypertrophy

(2008) Makhosazane Zungu et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Susceptibility to systolic dysfunction in the myocardium from chronically infarcted spontaneously hypertensive rats

(2007) Gavin R. Norton et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Dose translation from animal to human studies revisited

(2007) Shannon Reagan-Shaw et al.   FASEB JOURNAL